GPX4 and myocardial ischemia: [49] demonstrated that ferrostatin-1 alleviated myocardial ischemia–reperfusion injury via enhancing the Xc−/GSH/GPX4 antioxidant axis, substantiating the clinical relevance of modulating ferroptosis.